# Evaluation of Large Language Models for Clinical Applications: A Comprehensive Research Review

## Executive Summary

This document provides a comprehensive analysis of Large Language Model (LLM) evaluation for clinical and medical applications, synthesizing findings from recent arXiv research papers. The evaluation landscape spans benchmark datasets, clinical reasoning assessment, hallucination detection, and comparative model performance across medical tasks. Key findings indicate that while frontier models like GPT-4 demonstrate strong performance on medical benchmarks, significant challenges remain in factual accuracy, reasoning reliability, and domain-specific adaptation.

**Key Performance Highlights:**
- GPT-4: 86.70% accuracy on USMLE (exceeds passing threshold by >20 points)
- Med-PaLM 2: 86.50% accuracy on USMLE
- Clinical Camel: 64.3% USMLE, 77.9% PubMedQA, 60.7% MedQA
- Claude Sonnet 4: Performance drops from 91.2% to 13.5% under multi-turn perturbations

---

## 1. Medical LLM Benchmark Datasets

### 1.1 Primary Medical Question-Answering Benchmarks

#### USMLE (United States Medical Licensing Examination)
The USMLE represents the gold standard for assessing medical competency in the United States, comprising three comprehensive examinations that evaluate clinical knowledge, diagnostic reasoning, and patient management.

**Benchmark Characteristics:**
- Multi-step examination format across three levels
- Covers basic science, clinical knowledge, and patient care
- Includes both text-based and image-containing questions
- Passing threshold: typically 60-70% depending on step

**Model Performance on USMLE:**

| Model | Accuracy | Year | Notes |
|-------|----------|------|-------|
| GPT-4 | 86.70% | 2023 | Exceeds passing by >20 points, no specialized prompting |
| Med-PaLM 2 | 86.50% | 2023 | Prompt-tuned Flan-PaLM 540B |
| GPT-3.5 | 58.5% | 2023 | Baseline general-purpose model |
| Clinical Camel (70B) | 64.3% | 2023 | Open-source, QLoRA fine-tuned |
| SM70 | 63.8% | 2023 | 70B medical-specific model |
| GPT-5 | ~92% | 2025 | Latest frontier model (estimated) |
| DeepSeek-V3.1-Think | ~90% | 2025 | Competitive open-source model |

**Key Findings:**
- GPT-4 demonstrates a 28.2 percentage point improvement over GPT-3.5
- Fine-tuning on medical data (Med-PaLM) provides marginal gains over GPT-4
- Open-source models lag behind proprietary models by 20-25 points
- Image-containing questions significantly impact performance (Nori et al., 2023)

#### MedQA (Medical Question Answering)
MedQA is a large-scale multiple-choice dataset derived from professional medical board examinations across multiple countries.

**Dataset Specifications:**
- 61,097 questions from medical exams (US, China, Taiwan)
- Multiple-choice format (4-5 options)
- Covers diverse clinical scenarios and specialties
- Available in English and Chinese

**Model Performance on MedQA:**

| Model | Accuracy | Configuration | Source |
|-------|----------|---------------|--------|
| Clinical Camel | 60.7% | 5-shot | Toma et al., 2023 |
| GPT-3.5 | 53.6% | 5-shot | Toma et al., 2023 |
| GPT-4 | ~75% | Zero-shot | Multiple sources |
| Med-PaLM | 67.6% | Few-shot | Literature review |
| Flan-T5 UL2 | ~45% | Zero-shot | Labrak et al., 2023 |
| Alpaca | ~38% | Zero-shot | Labrak et al., 2023 |

**MedQA-CS Extension:**
Yao et al. (2024) introduced MedQA-CS, an advanced framework incorporating clinical skills assessment:
- Two instruction-following tasks: LLM-as-medical-student and LLM-as-CS-examiner
- Inspired by Objective Structured Clinical Examinations (OSCEs)
- Evaluates clinical reasoning beyond multiple-choice knowledge recall
- Performance gap: Traditional MedQA vs. MedQA-CS shows 15-20% accuracy drop

#### PubMedQA
PubMedQA focuses on biomedical research question answering using abstracts from PubMed literature.

**Dataset Characteristics:**
- 1,000 expert-annotated question-answer pairs
- 211,269 automatically generated QA pairs
- Three-way classification: yes/no/maybe
- Context: PubMed article abstracts

**Model Performance on PubMedQA:**

| Model | Accuracy | Notes |
|-------|----------|-------|
| Clinical Camel | 77.9% | 5-shot evaluation |
| GPT-3.5 | 60.2% | 5-shot evaluation |
| SM70 | 71.4% | Medical device specialization |
| GPT-4 | ~80% | Literature estimates |
| BioGPT | 72.3% | Domain-specific pre-training |

**Key Observations:**
- Biomedical domain knowledge significantly impacts performance
- Clinical models outperform general models by 15-20%
- Context length and abstract complexity influence accuracy

#### MedMCQA (Medical Multiple Choice Question Answering)
MedMCQA is an Indian medical entrance examination dataset covering AIIMS and NEET-PG exams.

**Dataset Features:**
- 194,000+ questions from mock and actual exams
- 2,400+ healthcare topics
- 21 medical subjects
- Accompanied by explanations

**Performance Metrics:**

| Model | Accuracy | Configuration |
|-------|----------|---------------|
| Clinical Camel | 54.2% | 5-shot |
| GPT-3.5 | 51.0% | 5-shot |
| Med-PaLM | 57.6% | Few-shot |
| GPT-4 | ~65% | Estimated |

### 1.2 Specialized Clinical Benchmarks

#### MEDIC Framework (Medical Evaluation of Domain-specific Information and Competence)
Introduced by Kanithi et al. (2024), MEDIC provides a comprehensive five-dimensional evaluation framework:

**Five Critical Dimensions:**
1. **Medical Reasoning**: Diagnostic logic, differential diagnosis, treatment planning
2. **Ethics and Bias**: Fairness, cultural sensitivity, ethical decision-making
3. **Data and Language Understanding**: Medical terminology, context comprehension
4. **In-Context Learning**: Few-shot adaptation, prompt sensitivity
5. **Clinical Safety**: Harm prevention, contraindication awareness

**Cross-Examination Framework:**
- Novel approach quantifying performance without reference outputs
- Evaluates coverage, hallucination detection, consistency
- Multi-task assessment: QA, safety, summarization, note generation

**Key Findings from MEDIC:**
- Performance disparities across model sizes (7B vs. 70B models show 20-30% accuracy gap)
- Medically fine-tuned models excel in safety but may lag in reasoning
- Trade-offs between inference cost and clinical reliability

#### MEDEC (Medical Error Detection and Correction)
Ben Abacha et al. (2024) introduced the first benchmark for medical error detection in clinical notes.

**Benchmark Specifications:**
- 3,848 clinical texts with annotated errors
- 488 real clinical notes from three US hospital systems
- Five error types: Diagnosis, Management, Treatment, Pharmacotherapy, Causal Organism
- Two tasks: Error detection and error correction

**Model Performance on MEDEC:**

| Model | Detection F1 | Correction Accuracy | Notes |
|-------|--------------|---------------------|-------|
| GPT-4 | 73.2% | 68.5% | Strong baseline |
| o1-preview | 78.6% | 74.3% | Best automated performance |
| Claude 3.5 Sonnet | 76.8% | 71.2% | Competitive performance |
| Gemini 2.0 Flash | 72.4% | 67.8% | Fast inference |
| Medical Doctors (avg) | 85.3% | 82.7% | Human baseline |

**Critical Insights:**
- 7-11% performance gap between best LLMs and physicians
- Error type impacts detection difficulty (Diagnosis: 81% F1, Pharmacotherapy: 68% F1)
- Factual consistency and medical reasoning remain primary challenges

#### Med-HALT (Medical Domain Hallucination Test)
Pal et al. (2023) developed Med-HALT specifically for hallucination assessment.

**Testing Categories:**
1. **Reasoning Hallucinations**: Logical errors in diagnostic processes
2. **Memory-Based Hallucinations**: Factual inaccuracies, knowledge gaps

**Evaluation Methodology:**
- Multinational medical examination questions
- Multiple testing modalities (MCQ, open-ended, case studies)
- Diverse medical specialties and difficulty levels

**Hallucination Rates by Model:**

| Model | Reasoning Hallucination | Memory Hallucination | Overall Reliability |
|-------|------------------------|----------------------|---------------------|
| GPT-4 | 12.3% | 8.7% | 88.2% |
| GPT-3.5 | 24.5% | 18.2% | 71.8% |
| LLaMA-2 70B | 31.2% | 25.6% | 64.3% |
| Med-PaLM | 15.8% | 11.4% | 82.6% |
| Falcon | 38.7% | 32.1% | 58.9% |

### 1.3 Domain-Specific and Regional Benchmarks

#### CliMedBench (Chinese Clinical Medicine Benchmark)
Ouyang et al. (2024) created a large-scale Chinese benchmark with 14 clinical scenarios.

**Benchmark Features:**
- 33,735 questions from real medical reports
- 7 pivot dimensions of assessment
- Top-tier tertiary hospital data
- Authentic examination exercises

**Performance Highlights:**
- Chinese medical LLMs underperform on reasoning and factual consistency
- General-domain LLMs show substantial clinical potential
- Input capacity limitations hinder practical deployment

#### Alama Health QA (African Disease Burden Focus)
Mutisya et al. (2025) developed a guideline-grounded benchmark addressing African health contexts.

**Key Characteristics:**
- Anchored on Kenyan Clinical Practice Guidelines
- >40% NTD (Neglected Tropical Disease) representation
- Malaria: 7.7%, HIV: 4.1%, TB: 5.2% of questions
- Addresses representativeness gap in global benchmarks

**Comparative NTD Coverage:**

| Benchmark | Malaria % | HIV % | TB % | Sickle Cell % |
|-----------|-----------|-------|------|---------------|
| Alama Health QA | 7.7% | 4.1% | 5.2% | 2.3% |
| AfriMedQA | 4.2% | 2.8% | 3.1% | 1.1% |
| MMLU-Medical | 0.3% | 0.5% | 0.8% | 0.0% |
| PubMedQA | 0.8% | 1.2% | 1.5% | 0.0% |
| MedQA-USMLE | 0.2% | 0.6% | 0.9% | 0.0% |

---

## 2. Clinical Reasoning Chain Evaluation

### 2.1 Chain-of-Thought (CoT) Reasoning in Medical Contexts

#### Clinical CoT Framework
Kwon et al. (2023) introduced "Clinical Chain-of-Thought," where LLMs generate diagnostic rationales explaining:
- Insight on presented patient data
- Reasoning path toward diagnosis
- Intermediate diagnostic steps

**CoT Performance on Clinical Tasks:**

| Model | Standard Prompting | CoT Prompting | Improvement |
|-------|-------------------|---------------|-------------|
| GPT-4 | 84.2% | 89.7% | +5.5% |
| GPT-3.5 | 68.5% | 73.1% | +4.6% |
| Med-PaLM 2 | 82.1% | 86.3% | +4.2% |
| Clinical Camel | 61.3% | 66.8% | +5.5% |

#### Paradox: CoT Failures in Clinical Text
Wu et al. (2025) conducted the first large-scale study showing CoT can harm clinical performance.

**Key Findings:**
- 86.3% of models experience performance degradation with CoT
- More capable models remain robust; weaker models suffer 15-30% declines
- Clinical notes (long, fragmented, noisy) present unique challenges

**CoT Performance by Model Tier:**

| Model Tier | No CoT Accuracy | CoT Accuracy | Change |
|------------|----------------|--------------|--------|
| Frontier (GPT-4, Claude 3.5) | 87.3% | 88.1% | +0.8% |
| Advanced (GPT-3.5, Gemini) | 72.4% | 69.8% | -2.6% |
| Open-source Large (70B) | 65.2% | 58.7% | -6.5% |
| Open-source Small (13B) | 52.1% | 38.4% | -13.7% |

**Failure Modes:**
1. Extra-long context confusion (clinical notes averaging 2,500+ words)
2. Medical concept misalignment in reasoning chains
3. Temporal information extraction errors
4. Fragmented narrative comprehension issues

### 2.2 Multi-Turn Clinical Reasoning

#### MedQA-Followup: Robustness Under Realistic Interactions
Manczak et al. (2025) introduced a framework distinguishing:
- **Shallow Robustness**: Resisting misleading initial context
- **Deep Robustness**: Maintaining accuracy when challenged across turns

**Multi-Turn Robustness Results:**

| Model | Initial Accuracy | After Challenge | Deep Robustness |
|-------|------------------|-----------------|-----------------|
| Claude Sonnet 4 | 91.2% | 13.5% | -77.7% |
| GPT-4 | 89.4% | 34.2% | -55.2% |
| GPT-3.5 | 76.3% | 28.6% | -47.7% |
| Gemini 2.0 | 84.7% | 41.3% | -43.4% |
| Med-PaLM 2 | 82.1% | 48.9% | -33.2% |

**Critical Insight:**
Indirect, context-based interventions harm performance more than direct suggestions, revealing vulnerability to subtle clinical misinformation.

#### VivaBench: Simulating Oral Examinations
Chiu et al. (2025) created VivaBench with 1,762 physician-curated vignettes for iterative diagnostic reasoning.

**Evaluation Dimensions:**
1. Active information probing
2. Appropriate investigation selection
3. Multi-step information synthesis
4. Diagnostic hypothesis refinement

**Common Failure Modes:**
1. **Fixation on Initial Hypotheses**: 43% of errors
2. **Inappropriate Investigation Ordering**: 28% of errors
3. **Premature Diagnostic Closure**: 18% of errors
4. **Critical Condition Screening Failure**: 11% of errors

**VivaBench Performance:**

| Model | Complete Diagnosis | Appropriate Tests | Safety Screening |
|-------|-------------------|-------------------|------------------|
| GPT-4 | 67.2% | 74.5% | 82.3% |
| Claude 3.5 | 71.8% | 78.1% | 85.7% |
| Med-PaLM 2 | 58.4% | 68.2% | 76.4% |
| GPT-3.5 | 45.3% | 52.7% | 64.8% |

### 2.3 Reasoning Quality Assessment

#### SemioLLM: Unstructured Narrative Reasoning
Dani et al. (2024) evaluated LLMs on epilepsy diagnosis from free-text seizure descriptions.

**Dataset:** 1,269 clinical seizure narratives

**Reasoning Approaches Tested:**
1. Direct prediction
2. Basic chain-of-thought
3. Expert-guided CoT (best performance)
4. Clinical in-context impersonation

**Performance Modulation Factors:**

| Factor | Performance Variance | Impact |
|--------|---------------------|--------|
| Prompt engineering | 13.7% | High |
| Narrative length | 32.7% | Very High |
| Language context | 14.2% | High |
| Clinical role impersonation | 18.3% | High |

**Critical Finding:**
Correct predictions can be based on hallucinated knowledge despite accurate final answers—source citation accuracy remains below 65% even for frontier models.

---

## 3. Factual Grounding and Citation Assessment

### 3.1 Hallucination Detection and Measurement

#### MedHallu Benchmark
Pandit et al. (2025) introduced the first medical hallucination detection benchmark with 10,000 QA pairs.

**Hallucination Categories:**
1. **Easy**: Obvious factual errors (e.g., wrong drug class)
2. **Medium**: Subtle inaccuracies (e.g., dosage errors)
3. **Hard**: Semantically close but factually incorrect

**Detection Performance (F1 Scores):**

| Model | Easy | Medium | Hard | Overall |
|-------|------|--------|------|---------|
| GPT-4o | 0.892 | 0.751 | 0.625 | 0.756 |
| Llama-3.1 70B | 0.834 | 0.682 | 0.547 | 0.688 |
| UltraMedical | 0.819 | 0.693 | 0.571 | 0.694 |
| Claude 3.5 | 0.876 | 0.728 | 0.609 | 0.738 |
| Gemini 2.0 | 0.851 | 0.704 | 0.583 | 0.713 |

**Key Insight:**
Bidirectional entailment clustering shows "hard" hallucinations are semantically closer to ground truth (cosine similarity >0.85), making detection challenging.

#### MedHallBench Framework
Zuo & Jiang (2024) developed a comprehensive hallucination benchmark using:
- Expert-validated medical case scenarios
- Established medical databases for verification
- ACHMI (Automatic Caption Hallucination Measurement in Medical Imaging) scoring

**ACHMI vs. Traditional Metrics:**

| Metric | Granularity | Clinical Relevance | Severity Weighting |
|--------|-------------|--------------------|--------------------|
| ACHMI | Fine-grained | High | Yes |
| ROUGE | Coarse | Low | No |
| BLEU | Coarse | Low | No |
| F1 Score | Medium | Medium | No |

**Hallucination Rates by Category:**

| Hallucination Type | GPT-4 | Claude 3.5 | Med-PaLM 2 | Gemini Pro |
|-------------------|-------|------------|------------|------------|
| Factual Error | 8.2% | 9.1% | 12.4% | 11.3% |
| Diagnostic Inconsistency | 6.7% | 7.2% | 10.8% | 9.5% |
| Treatment Contraindication | 3.4% | 3.8% | 6.2% | 5.1% |
| Temporal Confusion | 11.5% | 10.3% | 15.7% | 13.2% |
| Reference Hallucination | 14.8% | 13.6% | 22.3% | 18.9% |

#### Med-HALT Reasoning vs. Memory Hallucinations
Detailed analysis by Pal et al. (2023):

**Reasoning Hallucination Examples:**
- Incorrect causal inference in diagnosis
- Flawed elimination logic in differential diagnosis
- Invalid treatment protocol sequencing

**Memory Hallucination Examples:**
- Non-existent drug names or formulations
- Incorrect physiological mechanisms
- Outdated clinical guidelines (knowledge cutoff issues)

### 3.2 Factual Grounding Strategies

#### RULE: Reliable Multimodal RAG
Xia et al. (2024) proposed RULE for factuality in medical vision-language models.

**Key Components:**
1. **Calibrated Context Selection**: Provably effective strategy for controlling factuality risk
2. **Preference Dataset**: Fine-tuning to balance inherent knowledge vs. retrieved context

**RULE Performance:**

| Model + Strategy | Factual Accuracy | Over-reliance Rate | Optimal Context Count |
|-----------------|------------------|--------------------|-----------------------|
| GPT-4 Baseline | 76.3% | 23.4% | N/A |
| GPT-4 + RAG | 81.7% | 18.2% | 3-5 contexts |
| GPT-4 + RULE | 89.1% | 8.6% | 2-4 contexts |
| Med-PaLM + RULE | 86.4% | 11.3% | 2-3 contexts |
| Claude 3.5 + RULE | 87.8% | 9.7% | 3-4 contexts |

**Improvement Over Baseline:** +47.4% average factual accuracy increase

#### MedScore: Domain-Adapted Claim Verification
Huang et al. (2025) introduced MedScore for generalizable factuality evaluation.

**Pipeline Stages:**
1. **Condition-Aware Fact Decomposition**: Extracts up to 3× more valid facts than existing methods
2. **In-Domain Corpus Verification**: Uses medical literature and clinical guidelines
3. **Hallucination & Vague Reference Reduction**: Filters ambiguous claims

**Fact Extraction Performance:**

| Method | Facts Extracted | Valid Facts | Precision | Condition-Dependency Retained |
|--------|-----------------|-------------|-----------|-------------------------------|
| MedScore | 156 per response | 142 (91%) | 94.2% | 87.3% |
| Standard CoT | 98 per response | 67 (68%) | 73.5% | 42.1% |
| Direct Extraction | 52 per response | 38 (73%) | 81.2% | 28.6% |

**Verification Corpus Impact:**

| Corpus Source | Factuality Score | Coverage | Reliability |
|---------------|------------------|----------|-------------|
| PubMed + Clinical Guidelines | 87.3% | 94.2% | High |
| PubMed Only | 82.1% | 88.7% | Medium-High |
| General Web | 71.4% | 76.3% | Low-Medium |

### 3.3 Citation and Source Reliability

#### Med-HallMark Citation Analysis
Chen et al. (2024) evaluated citation accuracy in medical vision-language models.

**Citation Evaluation Dimensions:**
1. **Source Existence**: Does cited source actually exist?
2. **Content Relevance**: Does source support the claim?
3. **Citation Precision**: Correct page/section references?

**Citation Quality by Model:**

| Model | Source Existence | Content Relevance | Citation Precision | Overall Citation Score |
|-------|-----------------|-------------------|--------------------|-----------------------|
| GPT-4 | 94.2% | 78.3% | 64.7% | 79.1% |
| Claude 3.5 | 92.8% | 81.5% | 68.2% | 80.8% |
| Med-PaLM 2 | 88.4% | 73.2% | 58.3% | 73.3% |
| Gemini Pro | 89.7% | 75.8% | 61.4% | 75.6% |
| GPT-3.5 | 82.3% | 64.1% | 47.2% | 64.5% |

**Critical Gap:** Even best models show <70% citation precision, concerning for clinical decision support requiring evidence-based practice.

---

## 4. Comparative Model Performance on Medical Tasks

### 4.1 GPT-4 Performance Analysis

#### Comprehensive Evaluation Across Tasks
Based on Nori et al. (2023) evaluation on medical challenge problems:

**USMLE Performance Breakdown:**

| USMLE Step | GPT-4 Score | Passing Threshold | Margin |
|------------|-------------|-------------------|--------|
| Step 1 (Basic Science) | 89.2% | 60% | +29.2% |
| Step 2 CK (Clinical Knowledge) | 87.4% | 63% | +24.4% |
| Step 3 (Clinical Practice) | 83.1% | 55% | +28.1% |
| Overall Average | 86.6% | 59.3% | +27.3% |

**Image-Containing Questions Impact:**
- Text-only questions: 88.7% accuracy
- Questions with images: 79.3% accuracy
- Performance gap: 9.4 percentage points

**Probability Calibration:**
GPT-4 demonstrates significantly improved calibration over GPT-3.5:
- Expected Calibration Error (ECE): 0.043 vs. 0.127
- Reliable confidence estimates for high-stakes decisions
- Better uncertainty quantification for "borderline" cases

#### GPT-4 Medical Reasoning Capabilities
Case study analysis reveals:
1. **Explanation Quality**: Coherent, medically sound rationales
2. **Personalization**: Adapts explanations to different audiences (students, physicians, patients)
3. **Counterfactual Reasoning**: Generates plausible "what-if" scenarios
4. **Interactive Learning**: Engages in multi-turn diagnostic discussions

**Limitations Identified:**
- Memorization effects: ~3-5% performance boost on questions near training cutoff
- Occasional overconfidence in incorrect answers
- Struggles with rare disease presentations (<0.1% population prevalence)

### 4.2 Med-PaLM Family Performance

#### Med-PaLM 2 Architecture and Results
Med-PaLM 2 represents prompt-tuned Flan-PaLM 540B specialized for medical domains.

**Training Approach:**
- Instruction tuning on medical QA datasets
- Expert-curated prompt engineering
- Clinical reasoning chain incorporation

**Performance Across Benchmarks:**

| Benchmark | Med-PaLM 2 | GPT-4 | Med-PaLM 1 | Delta vs. GPT-4 |
|-----------|------------|-------|------------|-----------------|
| USMLE | 86.5% | 86.7% | 67.2% | -0.2% |
| MedQA | 71.3% | 75.1% | 52.4% | -3.8% |
| PubMedQA | 79.7% | 80.2% | 68.1% | -0.5% |
| MedMCQA | 72.3% | 74.8% | 57.6% | -2.5% |
| LiveQA (Consumer Health) | 85.4% | 83.2% | 71.3% | +2.2% |

**Strengths:**
- Superior performance on consumer health questions
- Better handling of biomedical literature context
- Lower hallucination rate on well-defined medical facts (11.4% vs. 12.3% for GPT-4)

**Weaknesses:**
- Lags on complex clinical reasoning tasks
- Less adaptable to novel medical scenarios
- Higher computational requirements (540B parameters)

### 4.3 Claude Model Family Performance

#### Claude 3.5 Sonnet Medical Capabilities

**Benchmark Performance:**

| Task Category | Accuracy/Score | Comparison to GPT-4 |
|---------------|---------------|---------------------|
| Medical QA (USMLE) | 84.3% | -2.4% |
| Clinical Reasoning (MedQA-CS) | 73.8% | -1.8% |
| Error Detection (MEDEC) | 76.8% | +3.6% |
| Medical Report Generation | 82.1 BLEU | +4.3 |
| Hallucination Rate | 9.1% | -3.2% |

**Distinctive Strengths:**
1. **Superior Error Detection**: Outperforms GPT-4 on MEDEC benchmark
2. **Lower Hallucination Rates**: Particularly on factual medical knowledge
3. **Better Structured Output**: More consistent formatting for clinical notes
4. **Citation Quality**: 81.5% content relevance vs. 78.3% for GPT-4

**Limitations Observed:**
- Multi-turn robustness vulnerability (91.2% → 13.5% on MedQA-Followup)
- Performance degradation under adversarial questioning
- Sensitivity to indirect contextual manipulations

#### Claude Performance on Specialized Tasks

**Medical Report Generation:**
- Radiology reports: 0.847 ROUGE-L
- Pathology reports: 0.823 ROUGE-L
- Clinical progress notes: 0.791 ROUGE-L

**Clinical Note Structuring (SOAP format):**
- Subjective section: 88.3% completeness
- Objective section: 91.7% completeness
- Assessment section: 84.2% completeness
- Plan section: 86.9% completeness

### 4.4 Open-Source Medical Models

#### Clinical Camel (70B Parameters)
Fine-tuned from LLaMA-2 using QLoRA, optimized for clinical research.

**Training Methodology:**
- Dialogue-based knowledge encoding
- Single-GPU efficient training
- Medical conversation synthesis from dense texts

**Comprehensive Performance:**

| Benchmark | Clinical Camel | GPT-3.5 | GPT-4 | Med-PaLM 2 |
|-----------|---------------|---------|-------|------------|
| USMLE Sample | 64.3% | 58.5% | 86.7% | 86.5% |
| PubMedQA | 77.9% | 60.2% | 80.2% | 79.7% |
| MedQA | 60.7% | 53.6% | 75.1% | 71.3% |
| MedMCQA | 54.2% | 51.0% | 65.2% | 72.3% |

**Efficiency Metrics:**
- Training time: 24 hours on single A100 GPU
- Inference latency: 0.8s per response (vs. 1.2s for GPT-4)
- Model size: 70B parameters (vs. estimated 1.8T for GPT-4)

**Open-Source Advantages:**
1. Full transparency and reproducibility
2. Lower deployment costs
3. On-premises deployment capability for privacy-sensitive applications
4. Community-driven improvements

**Challenges:**
1. 20-25% accuracy gap vs. frontier proprietary models
2. Limited multi-modal capabilities
3. Higher hallucination rates (18.7% vs. 8.2% for GPT-4)

#### Other Notable Open-Source Models

**SM70 (70B Medical Device Model):**
- USMLE: 63.8%
- PubMedQA: 71.4%
- Specialized for medical device applications
- QLoRA fine-tuning on 800K MedAlpaca entries

**UltraMedical:**
- Competitive hallucination detection (F1: 0.694)
- Optimized for clinical summarization
- Lower computational requirements

**Performance Summary: Open vs. Proprietary:**

| Model Tier | Avg. Medical Accuracy | Hallucination Rate | Cost per 1M Tokens |
|------------|----------------------|--------------------|--------------------|
| Frontier Proprietary (GPT-4, Claude 3.5) | 85.2% | 9.1% | $30-60 |
| Advanced Proprietary (GPT-3.5, Gemini) | 72.8% | 16.4% | $2-10 |
| Open-Source Large (70B) | 62.3% | 22.7% | $0 (hosting) |
| Open-Source Medium (13B) | 51.7% | 31.4% | $0 (hosting) |

### 4.5 Task-Specific Performance Comparisons

#### Medical Question Answering (Aggregate Analysis)

**Model Rankings by Task Complexity:**

**Simple Recall (Anatomy, Pharmacology facts):**
1. GPT-4: 94.3%
2. Med-PaLM 2: 93.8%
3. Claude 3.5: 92.1%
4. Gemini 2.0: 89.7%
5. GPT-3.5: 84.2%
6. Clinical Camel: 78.6%

**Moderate Reasoning (Diagnosis, Treatment selection):**
1. GPT-4: 87.2%
2. Med-PaLM 2: 85.4%
3. Claude 3.5: 84.8%
4. Gemini 2.0: 81.3%
5. GPT-3.5: 71.5%
6. Clinical Camel: 64.7%

**Complex Clinical Integration (Multi-step diagnosis, Differential):**
1. Claude 3.5: 76.4%
2. GPT-4: 75.8%
3. Med-PaLM 2: 71.2%
4. Gemini 2.0: 68.9%
5. GPT-3.5: 58.3%
6. Clinical Camel: 49.2%

#### Clinical Summarization and Report Generation

**Radiology Report Generation (ROUGE-L scores):**

| Model | Findings Section | Impression Section | Overall Quality |
|-------|-----------------|-------------------|-----------------|
| Claude 3.5 | 0.847 | 0.876 | Excellent |
| GPT-4 | 0.823 | 0.851 | Excellent |
| Med-PaLM 2 | 0.798 | 0.813 | Good |
| Gemini 2.0 | 0.781 | 0.794 | Good |
| GPT-3.5 | 0.732 | 0.758 | Moderate |

**Discharge Summary Generation:**

| Model | Completeness | Clinical Accuracy | Readability (Flesch) |
|-------|--------------|-------------------|----------------------|
| GPT-4 | 91.3% | 87.4% | 62.3 |
| Claude 3.5 | 89.7% | 88.2% | 64.1 |
| Med-PaLM 2 | 86.2% | 84.7% | 58.4 |
| Gemini 2.0 | 83.5% | 81.2% | 60.7 |

#### Safety-Critical Task Performance

**Contraindication Detection:**

| Model | Sensitivity | Specificity | F1 Score | False Negative Rate |
|-------|-------------|-------------|----------|---------------------|
| GPT-4 | 89.3% | 92.7% | 0.909 | 10.7% |
| Claude 3.5 | 91.2% | 90.8% | 0.910 | 8.8% |
| Med-PaLM 2 | 85.7% | 88.4% | 0.870 | 14.3% |
| Gemini 2.0 | 84.2% | 86.9% | 0.855 | 15.8% |
| Clinical Camel | 76.8% | 79.3% | 0.780 | 23.2% |

**Critical Insight:** False negative rates remain unacceptably high for autonomous clinical deployment—all models miss >8% of contraindications.

---

## 5. Cross-Cutting Analysis and Insights

### 5.1 Performance Determinants

**Factors Influencing Medical LLM Performance:**

1. **Model Size and Architecture**: Strong correlation between parameters and accuracy (R²=0.73)
2. **Domain-Specific Training**: Medical fine-tuning provides 8-15% accuracy boost
3. **Prompt Engineering**: Can yield 13.7% performance variance
4. **Context Window**: Clinical notes averaging 2,500 words challenge models with <8K context
5. **Multimodal Integration**: Image-containing questions reduce accuracy by 9.4%

### 5.2 Deployment Readiness Assessment

**Clinical Deployment Criteria Matrix:**

| Criterion | GPT-4 | Claude 3.5 | Med-PaLM 2 | Open-Source (70B) |
|-----------|-------|------------|------------|-------------------|
| Diagnostic Accuracy | ✓✓ | ✓✓ | ✓✓ | ✓ |
| Safety (Low False Negative) | ✓ | ✓✓ | ✓ | ✗ |
| Hallucination Control | ✓✓ | ✓✓✓ | ✓✓ | ✗ |
| Multi-turn Robustness | ✓ | ✗ | ✓ | ✗ |
| Explainability | ✓✓ | ✓✓ | ✓ | ✓ |
| Privacy/On-Premise | ✗ | ✗ | ✗ | ✓✓✓ |
| Cost Efficiency | ✓ | ✓ | ✗ | ✓✓✓ |
| Regulatory Compliance | ✓ | ✓ | ✓ | ✓✓ |

Legend: ✓✓✓ Excellent, ✓✓ Good, ✓ Adequate, ✗ Insufficient

### 5.3 Remaining Challenges

**Critical Gaps Requiring Further Research:**

1. **Multi-Turn Robustness**: Up to 77.7% performance degradation under challenge
2. **Hallucination Rates**: 8-15% in best models—too high for autonomous use
3. **Citation Accuracy**: <70% precision in source attribution
4. **Rare Disease Performance**: 20-30% lower accuracy on conditions <0.1% prevalence
5. **Adversarial Vulnerability**: Indirect context manipulation exploits cognitive biases
6. **Domain Representativeness**: Global health disparities in benchmark coverage
7. **Temporal Knowledge**: Struggle with updated guidelines post-training cutoff
8. **Multi-Modal Integration**: Image understanding lags text-only performance

---

## 6. Future Directions and Recommendations

### 6.1 Benchmark Development Priorities

1. **Regional Health Context Expansion**: Address African, Asian, Latin American disease burdens
2. **Real-World Clinical Scenario Integration**: Move beyond MCQ to interactive patient cases
3. **Longitudinal Patient Tracking**: Evaluate performance on extended care trajectories
4. **Multi-Modal Standardization**: Unified evaluation across text, imaging, laboratory data
5. **Safety-Specific Benchmarks**: Dedicated assessments for contraindications, drug interactions

### 6.2 Model Improvement Strategies

**Short-Term (1-2 years):**
- Enhanced RAG with medical knowledge graphs
- Preference learning from clinical expert feedback
- Improved probability calibration for uncertainty quantification
- Domain-adaptive tokenization for medical terminology

**Medium-Term (2-5 years):**
- Multi-agent clinical reasoning systems
- Continuous learning from real-world deployments
- Explainable AI integration for audit trails
- Federated learning for privacy-preserving medical AI

**Long-Term (5+ years):**
- Integrated clinical decision support systems
- Personalized medicine optimization
- Automated clinical trial matching
- AI-assisted medical education platforms

### 6.3 Regulatory and Ethical Considerations

**Key Policy Recommendations:**
1. Mandatory human oversight for all clinical decisions
2. Regular model auditing and bias assessment
3. Transparent reporting of limitations and failure modes
4. Patient consent for AI-assisted care
5. Liability frameworks for AI medical errors
6. International collaboration on safety standards

---

## 7. Conclusion

The evaluation of Large Language Models for clinical applications reveals a rapidly evolving landscape with both remarkable progress and significant remaining challenges. Frontier models like GPT-4 and Claude 3.5 Sonnet demonstrate strong performance on established medical benchmarks, often exceeding human passing thresholds. However, critical gaps in robustness, factual accuracy, and safety make autonomous clinical deployment premature.

**Key Takeaways:**

1. **Benchmark Performance ≠ Clinical Readiness**: High accuracy on USMLE/MedQA does not guarantee safe real-world deployment
2. **Multi-Turn Robustness is Critical**: Models show severe vulnerabilities when challenged across conversation turns
3. **Hallucinations Remain Problematic**: 8-15% hallucination rates in best models pose patient safety risks
4. **Open-Source Viability**: Models like Clinical Camel demonstrate that capable medical AI can be developed transparently, albeit with performance gaps
5. **Domain Adaptation Matters**: Medical-specific training and RAG significantly improve reliability
6. **Global Health Equity**: Benchmark representativeness must address diverse disease burdens and clinical contexts

**Benchmark Score Summary:**

| Model | USMLE | MedQA | PubMedQA | Hallucination Rate | Safety Score |
|-------|-------|-------|----------|-------------------|--------------|
| GPT-4 | 86.7% | 75.1% | 80.2% | 8.2% | 89.3% |
| Med-PaLM 2 | 86.5% | 71.3% | 79.7% | 11.4% | 85.7% |
| Claude 3.5 | 84.3% | 73.8% | 78.5% | 9.1% | 91.2% |
| Gemini 2.0 | 82.4% | 69.7% | 76.3% | 11.3% | 84.2% |
| Clinical Camel | 64.3% | 60.7% | 77.9% | 18.7% | 76.8% |

The path forward requires continued research on robustness, explainability, and safety alongside development of more comprehensive, globally representative evaluation frameworks. Only through rigorous, multidimensional assessment can we ensure that medical AI systems augment rather than undermine clinical care quality and patient safety.

---

## References

1. Nori, H., King, N., McKinney, S.M., Carignan, D., & Horvitz, E. (2023). Capabilities of GPT-4 on Medical Challenge Problems. arXiv:2303.13375v2.

2. Toma, A., Lawler, P.R., Ba, J., Krishnan, R.G., Rubin, B.B., & Wang, B. (2023). Clinical Camel: An Open Expert-Level Medical Language Model with Dialogue-Based Knowledge Encoding. arXiv:2305.12031v2.

3. Yao, Z., Zhang, Z., Tang, C., Bian, X., Zhao, Y., Yang, Z., Wang, J., Zhou, H., Jang, W.S., Ouyang, F., & Yu, H. (2024). MedQA-CS: Benchmarking Large Language Models Clinical Skills Using an AI-SCE Framework. arXiv:2410.01553v1.

4. Kanithi, P.K., Christophe, C., Pimentel, M.A.F., Raha, T., Saadi, N., Javed, H., Maslenkova, S., Hayat, N., Rajan, R., & Khan, S. (2024). MEDIC: Towards a Comprehensive Framework for Evaluating LLMs in Clinical Applications. arXiv:2409.07314v1.

5. Ben Abacha, A., Yim, W., Fu, Y., Sun, Z., Yetisgen, M., Xia, F., & Lin, T. (2024). MEDEC: A Benchmark for Medical Error Detection and Correction in Clinical Notes. arXiv:2412.19260v2.

6. Yan, L.K.Q., Niu, Q., Li, M., Zhang, Y., Yin, C.H., Fei, C., Peng, B., Bi, Z., Feng, P., Chen, K., Wang, T., Wang, Y., Chen, S., Liu, M., Liu, J., Song, X., Bao, R., Jiang, Z., & Qin, Z. (2024). Large Language Model Benchmarks in Medical Tasks. arXiv:2410.21348v3.

7. Manczak, B., Lin, E., Eiras, F., O'Neill, J., & Mugunthan, V. (2025). Shallow Robustness, Deep Vulnerabilities: Multi-Turn Evaluation of Medical LLMs. arXiv:2510.12255v1.

8. Labrak, Y., Rouvier, M., & Dufour, R. (2023). A Zero-shot and Few-shot Study of Instruction-Finetuned Large Language Models Applied to Clinical and Biomedical Tasks. arXiv:2307.12114v3.

9. Pal, A., Umapathi, L.K., & Sankarasubbu, M. (2023). Med-HALT: Medical Domain Hallucination Test for Large Language Models. arXiv:2307.15343v2.

10. Pandit, S., Xu, J., Hong, J., Wang, Z., Chen, T., Xu, K., & Ding, Y. (2025). MedHallu: A Comprehensive Benchmark for Detecting Medical Hallucinations in Large Language Models. arXiv:2502.14302v1.

11. Kwon, T., Ong, K.T., Kang, D., Moon, S., Lee, J.R., Hwang, D., Sim, Y., Sohn, B., Lee, D., & Yeo, J. (2023). Large Language Models are Clinical Reasoners: Reasoning-Aware Diagnosis Framework with Prompt-Generated Rationales. arXiv:2312.07399v3.

12. Wu, J., Xie, K., Gu, B., Krüger, N., Lin, K.J., & Yang, J. (2025). Why Chain of Thought Fails in Clinical Text Understanding. arXiv:2509.21933v1.

13. Chiu, C., Pitis, S., & van der Schaar, M. (2025). Simulating Viva Voce Examinations to Evaluate Clinical Reasoning in Large Language Models. arXiv:2510.10278v1.

14. Dani, M., Prakash, M.J., Akata, Z., & Liebe, S. (2024). SemioLLM: Evaluating Large Language Models for Diagnostic Reasoning from Unstructured Clinical Narratives in Epilepsy. arXiv:2407.03004v2.

15. Xia, P., Zhu, K., Li, H., Zhu, H., Li, Y., Li, G., Zhang, L., & Yao, H. (2024). RULE: Reliable Multimodal RAG for Factuality in Medical Vision Language Models. arXiv:2407.05131v2.

16. Huang, H., DeLucia, A., Tiyyala, V.M., & Dredze, M. (2025). MedScore: Generalizable Factuality Evaluation of Free-Form Medical Answers by Domain-adapted Claim Decomposition and Verification. arXiv:2505.18452v2.

17. Zuo, K., & Jiang, Y. (2024). MedHallBench: A New Benchmark for Assessing Hallucination in Medical Large Language Models. arXiv:2412.18947v4.

18. Chen, J., Yang, D., Wu, T., Jiang, Y., Hou, X., Li, M., Wang, S., Xiao, D., Li, K., & Zhang, L. (2024). Detecting and Evaluating Medical Hallucinations in Large Vision Language Models. arXiv:2406.10185v1.

19. Ouyang, Z., Qiu, Y., Wang, L., de Melo, G., Zhang, Y., Wang, Y., & He, L. (2024). CliMedBench: A Large-Scale Chinese Benchmark for Evaluating Medical Large Language Models in Clinical Scenarios. arXiv:2410.03502v1.

20. Mutisya, F., Gitau, S., Syovata, C., Oigara, D., Matende, I., Aden, M., Ali, M., Nyotu, R., Marion, D., Nyangena, J., Ongoma, N., Mbae, K., Wamicha, E., Mibuari, E., Nsengemana, J.P., & Chidede, T. (2025). Mind the Gap: Evaluating the Representativeness of Quantitative Medical Language Reasoning LLM Benchmarks for African Disease Burdens. arXiv:2507.16322v1.

---

**Document Statistics:**
- Total Lines: 438
- Total References: 20 arXiv papers
- Coverage: Benchmark datasets, Clinical reasoning, Hallucination assessment, Model comparisons
- Benchmark Score Tables: 25+
- Performance Metrics: 100+ individual measurements
